SEC Form 4 · Insider disclosures

Recent Insider Buying

Recent purchases grouped by company. A P-code purchase may be open-market or private; check the filing for context.

Updates delayedUpdated Some disclosures are unavailable

Purchase rows791
Sale rows3,373
Purchase value (USD)US$649.43M
Sale value (USD)US$72.39B

Recent company disclosures

284 companies · 791 rows
SRTA

Strata Critical Medical, Inc.

Purchase total ≈ US$10K

1 transaction rows · 1 filings

LAUCK ANDREW

Purchase
Director disclosed purchase of 2,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 1.17%; approximately 173K shares afterward

Calculated transaction value approximately US$10K
LXRX

LEXICON PHARMACEUTICALS, INC.

Purchase total ≈ US$50K

1 transaction rows · 1 filings

Exton Michael

Purchase
CEO / Director disclosed purchase of 30,064 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 10.07%; approximately 328K shares afterward

Calculated transaction value approximately US$50K
MSC

STUDIO CITY INTERNATIONAL HOLDINGS Ltd

Purchase total ≈ US$19.93K

2 transaction rows · 1 filings

HO LAWRENCE YAU LUNG

Purchase
Director disclosed purchase of 8,696 shares

Filing did not check the 10b5-1 plan indicator

Approximately 463M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.28K

HO LAWRENCE YAU LUNG

Purchase
Director disclosed purchase of 63,552 shares

Filing did not check the 10b5-1 plan indicator

Approximately 463M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$17.65K
FICO

FAIR ISAAC CORP

Purchase total ≈ US$20.46K

2 transaction rows · 1 filings

Rey David A

Purchase
Director disclosed purchase of 8 shares

Filing did not check the 10b5-1 plan indicator

Approximately 5.06K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$13.09K

Rey David A

Purchase
Director disclosed purchase of 8 shares

Filing did not check the 10b5-1 plan indicator

Approximately 5.06K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$7.37K
KMI

KINDER MORGAN, INC.

Purchase total ≈ US$14.99M

1 transaction rows · 1 filings

KINDER RICHARD D

Purchase
Officer / Director / 10% owner disclosed purchase of 500,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.20%; approximately 247M shares afterward

Calculated transaction value approximately US$14.99M
MDGL

MADRIGAL PHARMACEUTICALS, INC.

Purchase total ≈ US$35.02M

5 transaction rows · 1 filings

BAKER BROS. ADVISORS LP / Baker Bros. Advisors (GP) LLC / BAKER FELIX / BAKER JULIAN / 667, L.P. / Baker Brothers Life Sciences LP

Purchase
Director disclosed purchase of 5,586 shares

Filing did not check the 10b5-1 plan indicator

Approximately 1.95M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.05M

BAKER BROS. ADVISORS LP / Baker Bros. Advisors (GP) LLC / BAKER FELIX / BAKER JULIAN / 667, L.P. / Baker Brothers Life Sciences LP

Purchase
Director disclosed purchase of 10,080 shares

Filing did not check the 10b5-1 plan indicator

Approximately 1.96M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$3.71M
Show 3 more transaction rows

BAKER BROS. ADVISORS LP / Baker Bros. Advisors (GP) LLC / BAKER FELIX / BAKER JULIAN / 667, L.P. / Baker Brothers Life Sciences LP

Purchase
Director disclosed purchase of 60,400 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.02M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$23.13M

BAKER BROS. ADVISORS LP / Baker Bros. Advisors (GP) LLC / BAKER FELIX / BAKER JULIAN / 667, L.P. / Baker Brothers Life Sciences LP

Purchase
Director disclosed purchase of 13,740 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.04M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$5.34M

BAKER BROS. ADVISORS LP / Baker Bros. Advisors (GP) LLC / BAKER FELIX / BAKER JULIAN / 667, L.P. / Baker Brothers Life Sciences LP

Purchase
Director disclosed purchase of 2,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.04M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$793.22K
FFAI

FARADAY FUTURE INTELLIGENT ELECTRIC INC.

Purchase total ≈ US$100

1 transaction rows · 1 filings

Wang Jiawei

Purchase
Officer / Director disclosed purchase of 1 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased this account's direct holdings from 0 to 1 shares

Calculated transaction value approximately US$100
KOD

Kodiak Sciences Inc.

Purchase total ≈ US$24.34M

4 transaction rows · 1 filings

BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIAN

Purchase
Director / 10% owner disclosed purchase of 8,742 shares

Filing did not check the 10b5-1 plan indicator

Approximately 1.68M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$861.17K

BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIAN

Purchase
Director / 10% owner disclosed purchase of 151,916 shares

Filing did not check the 10b5-1 plan indicator

Approximately 20.3M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$14.97M
Show 2 more transaction rows

BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIAN

Purchase
Director / 10% owner disclosed purchase of 4,703 shares

Filing did not check the 10b5-1 plan indicator

Approximately 1.68M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$463.29K

BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIAN

Purchase
Director / 10% owner disclosed purchase of 81,729 shares

Filing did not check the 10b5-1 plan indicator

Approximately 20.4M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$8.05M
DFH

Dream Finders Homes, Inc.

Purchase total ≈ US$10.53K

1 transaction rows · 1 filings

Sturm Len

Purchase
Director disclosed purchase of 1,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 3.25%; approximately 31.7K shares afterward

Calculated transaction value approximately US$10.53K
MXF

MEXICO EQUITY & INCOME FUND INC

Purchase total ≈ US$1.1M

3 transaction rows · 3 filings

Saba Capital Management, L.P.

Purchase
10% owner disclosed purchase of 24,115 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately 0.96%; approximately 2.52M shares afterward

Calculated transaction value approximately US$499.66K

Saba Capital Management, L.P.

Purchase
10% owner disclosed purchase of 15,011 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately 0.60%; approximately 2.49M shares afterward

Calculated transaction value approximately US$314.48K
Show 1 more transaction rows

Saba Capital Management, L.P.

Purchase
10% owner disclosed purchase of 13,804 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately 0.55%; approximately 2.48M shares afterward

Calculated transaction value approximately US$283.53K
CVS

CVS HEALTH Corp

Purchase total ≈ US$2M

1 transaction rows · 1 filings

Shah Prem S

Purchase
Officer disclosed purchase of 23,855 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 36.89%; approximately 88.5K shares afterward

Calculated transaction value approximately US$2M
ECF

ELLSWORTH GROWTH & INCOME FUND LTD

Purchase total ≈ US$87.85K

1 transaction rows · 1 filings

Saba Capital Management, L.P.

Purchase
10% owner disclosed purchase of 7,747 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately 0.42%; approximately 1.82M shares afterward

Calculated transaction value approximately US$87.85K
Sources, coverage & updates
SEC filing dates: 2026-11-04 — 2026-11-13 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Nov 11, 7:34 PM ET

Partial coverage; backfill in progress

Discovered filings 3,950 · Parsed 3,950 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 95 unavailable, unverified or non-USD amounts are excluded. 1836 filings · 1788 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗